IAM
Iambic Therapeutics, Inc. · Healthcare
Insiders bought $11.5M net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Oct 19, 2026
Insider Buying
$11.5M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Oct 20, 2026
Rachlin Evan Lockwood
Iambic Therapeutics, Inc. (IAM) has 10 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Oct 20, 2026.
Inside the rolling window, 1 insider at Iambic Therapeutics, Inc. reported 1 open-market purchase totaling $11.5M and no open-market sales. Insiders have net bought $11.5M over the trailing 6 months. The largest single insider purchase in this window was $11.5M by Director Rachlin Evan Lockwood on Oct 16, 2026.
- Industry:Software - Application
- CEO:Thomas Miller
- HQ:San Diego, CA, US
- IPO:2026-10-15
| Source | |||||||
|---|---|---|---|---|---|---|---|
Rachlin Evan LockwoodFirst filing | Director | Purchase | 718,750 | $11.5M | Oct 19 | -3.3% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does IAM have?
Iambic Therapeutics, Inc. (IAM) has 10 SEC Form 4 filings (18 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Oct 20, 2026.
When was the most recent SEC Form 4 filing for IAM?
The most recent Form 4 filing for IAM on Tracefour is dated Oct 20, 2026.
What is the net insider flow at IAM over the last 6 months?
Over the trailing 180 days, insiders at IAM have net bought $11.5M based on SEC Form 4 disclosures.
What was the largest insider purchase at IAM?
The largest single insider open-market purchase at IAM in the rolling window was $11.5M by Director Rachlin Evan Lockwood on 2026-10-16.
What is the total insider buy and sell value at IAM in the current window?
Inside the rolling window, insiders at IAM bought $11.5M and sold $0 based on SEC Form 4 filings.
Can I get alerts for IAM insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Iambic Therapeutics, Inc. (IAM). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Iambic Therapeutics, Inc. is in the Healthcare sector.